Equifax stock is trading -10.89% below its average target price of $280.65 after dropping -1.3% during today's morning session. Analysts are giving the Large-Cap Diversified Financial company an average rating of buy and target prices ranging from $240.0 to $300.0 per share.
Equifax's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 2.6%. The stock's short ratio is 2.61. The company's insiders own 0.51% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 100.2%. In conclusion, we believe there is mixed market sentiment regarding Equifax.
Institutions Invested in Equifax
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2025-06-30 | Vanguard Group Inc | 12% | 14,966,903 | $3,743,222,531 |
2025-06-30 | Capital International Investors | 8% | 10,478,466 | $2,620,664,410 |
2025-06-30 | Blackrock Inc. | 7% | 9,049,543 | $2,263,290,759 |
2025-03-31 | Price (T.Rowe) Associates Inc | 6% | 7,037,804 | $1,760,154,823 |
2025-03-31 | State Street Corporation | 4% | 4,901,983 | $1,225,985,978 |
2025-03-31 | Harris Associates L.P. | 4% | 4,570,557 | $1,143,096,333 |
2025-03-31 | Morgan Stanley | 3% | 3,734,413 | $933,976,714 |
2025-06-30 | Massachusetts Financial Services Co. | 3% | 3,350,418 | $837,939,562 |
2025-06-30 | Geode Capital Management, LLC | 3% | 3,142,763 | $786,005,045 |
2025-06-30 | Kayne Anderson Rudnick Investment Management LLC | 2% | 3,083,919 | $771,288,160 |